Related Experiment Video
Updated: Jul 13, 2026

The Soft Agar Colony Formation Assay
Published on: October 27, 2014
Wwox suppresses prostate cancer cell growth through modulation of ErbB2-mediated androgen receptor signaling
Haiyan R Qin1, Dimitrios Iliopoulos, Tatsuya Nakamura
1Department of Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio 43210, USA.
Abstract:
The expression of the WWOX tumor suppressor gene is lost or reduced in a large fraction of various cancers, including prostate cancer. We previously reported that Wwox overexpression induced apoptosis and suppressed prostate cancer growth in vitro and in vivo. In this study, pathways through which Wwox contributes to control of prostate cancer cell growth have been investigated. We found that Wwox interacts with Ap2gamma and prevents it from entering the nucleus to bind the ERBB2 promoter region to activate transcription of ERBB2, a mediator of androgen receptor activity and prostate cancer cell growth at limiting androgen concentration. Ectopic expression of Wwox reduced ErbB2 protein expression in vitro and expression of Wwox protein inversely correlated with expression of ErbB2 protein in prostate cancer tissues. Furthermore, Wwox suppressed Ap2gamma/ErbB2-induced prostate cancer cell growth and suppressed prostate-specific antigen secretion through interaction with Ap2gamma and down-modulation of ErbB2, an effect that required functional androgen receptor.
Insights
The WWOX tumor suppressor gene, often lost in prostate cancer, inhibits cancer growth by blocking ERBB2 activation. WWOX
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The WWOX tumor suppressor gene's expression is frequently lost or reduced in various cancers, notably prostate cancer.
- Previous research demonstrated that WWOX overexpression induces apoptosis and suppresses prostate cancer progression both in vitro and in vivo.
Purpose of the Study:
- To investigate the specific molecular pathways through which WWOX exerts its tumor-suppressive effects on prostate cancer cell growth.
- To elucidate the interaction between WWOX, Ap2gamma, and ERBB2 in the context of prostate cancer.
Main Methods:
- Investigated the interaction between WWOX and Ap2gamma.
- Assessed the effect of WWOX on the nuclear localization of Ap2gamma and its binding to the ERBB2 promoter.
- Measured ERBB2 and prostate-specific antigen (PSA) expression levels.
- Correlated WWOX and ErbB2 protein expression in prostate cancer tissues.
Main Results:
- WWOX interacts with Ap2gamma, preventing its nuclear entry and subsequent activation of the ERBB2 promoter.
- Ectopic WWOX expression reduced ErbB2 protein levels in vitro, and WWOX protein levels inversely correlated with ErbB2 protein levels in prostate cancer tissues.
- WWOX suppressed Ap2gamma/ErbB2-mediated prostate cancer cell growth and PSA secretion, an effect dependent on functional androgen receptor signaling.
Conclusions:
- WWOX acts as a critical regulator of prostate cancer cell proliferation by inhibiting the Ap2gamma/ERBB2 pathway, particularly under limiting androgen conditions.
- The tumor-suppressive function of WWOX in prostate cancer is mediated through the down-modulation of ErbB2 and requires an intact androgen receptor pathway.
Related Concept Videos
Canonical Wnt Signaling Pathway
Canonical Wnt Signaling Pathway
Non-Canonical Wnt Signaling Pathways
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
